The DOI matches its Crossref record.
Time From Treatment to Subsequent Diagnosis of Brain Metastases in Stage III Non–Small-Cell Lung Cancer: A Retrospective Review by the Southwest Oncology Group
Open accessAbstract
Purpose: A retrospective review of the Southwest Oncology Group (SWOG) database was undertaken to review the incidence and timing of diagnosis of brain metastases in patients undergoing combined-modality therapy for stage III non–small-cell lung cancer (NSCLC). Patients and Methods: Four hundred twenty-two eligible, assessable patients with stage IIIA/B NSCLC were treated on four SWOG protocols. Treatment varied with protocol but consisted of concurrent cisplatin-etoposide and radiation in all patients, with a surgery arm in two of the four protocols. Results: Of the 422 total patients, 268 (64%) have experienced disease progression; 54 relapses (20%) were in brain only, 17 (6.5%) were in brain and other sites simultaneously, and 197 (63.5%) were in sites other than brain. Of the 268 patients with disease progression, progression in the brain only, in the brain and other sites, and not in the brain occurred in 20%, 6%, and 74% of patients, respectively. Time from treatment to diagnosis of disease progression in the brain in 71 patients was as follows: during treatment, 16 relapses (22.5%); 0 to 16 weeks after treatment, 17 relapses (24%); 16 weeks to 6 months after treatment, 10 relapses (14%); 6 to 12 months after treatment, 16 relapses (22.5%); and more than 12 months after treatment, 12 relapses (17%). Nonsquamous histology and young patient age were the only significant predictors for increased risk of early relapse with brain metastases. Conclusion: Brain metastases often develop early in the course of treatment for stage IIIA/B NSCLC. The statistical designs of ongoing trials of prophylactic cranial irradiation in stage III NSCLC have taken this into account.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
Chen, Q., Boire, A., Jin, X., Valiente, M., Er, E. E., Lopez-Soto, A., S. Jacob, L., Patwa, R., Shah, H., Xu, K., et al. (2016) · Nature · doi:10.1038/nature18268 · Cited by 969
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
Eberhardt, W. E. E., De Ruysscher, D., Weder, W., Le Péchoux, C., De Leyn, P., Hoffmann, H., Westeel, V., Stahel, R., Felip, E., Peters, S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv187 · Cited by 401
Sun, A., Bae, K., Gore, E. M., Movsas, B., Wong, S. J., Meyers, C. A., Bonner, J. A., Schild, S. E., Gaspar, L. E., Bogart, J. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.6053 · Cited by 369
Self-citationGore, E. M., Bae, K., Wong, S. J., Sun, A., Bonner, J. A., Schild, S. E., Gaspar, L. E., Bogart, J. A., Werner-Wasik, M., & Choy, H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.1609 · Cited by 308
Self-citationDavis, F. G., Dolecek, T. A., McCarthy, B. J., & Villano, J. L. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos152 · Cited by 256
Su, P.-L., Wu, Y.-L., Chang, W.-Y., Ho, C.-L., Tseng, Y.-L., Lai, W.-W., Su, W.-C., Lin, C.-C., & Yang, S.-C. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918797589 · Cited by 49
Metadata
- Authors
- Gaspar, L. E., Chansky, K., Albain, K. S., Vallieres, E., Rusch, V., Crowley, J. J., Livingston, R. B., & Gandara, D. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-05-01
- Volume
- 23
- Issue
- 13
- Pages
- 2955-2961
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2109950864
- Cited by
- 165
- References
- 0
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.